Warner Bros. Discovery, Inc. (WBD) CFO reports option exercises and share dispositions
Rhea-AI Filing Summary
Warner Bros. Discovery, Inc.'s Chief Financial Officer reported option exercises and share dispositions in Series A common stock on December 10, 2025.
The officer exercised employee stock options covering 92,592 and 150,402 Series A shares at exercise prices of $29.08 and $25.7 per share, then disposed of 92,592 and 150,402 shares at $29.5 per share.
Following these transactions, the officer directly beneficially owns 918,940 Series A shares, plus 14,140 shares held as custodian and 13,045 shares held by a spouse. The transactions were made under a Rule 10b5-1 trading arrangement entered on March 4, 2025.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Warner Bros. Discovery (WBD) report for its CFO?
The Chief Financial Officer of Warner Bros. Discovery, Inc. reported exercising employee stock options for 92,592 and 150,402 Series A common shares, then disposing of the same respective amounts of Series A shares at $29.5 per share.
When did the Warner Bros. Discovery CFO's reported transactions take place?
The reported transactions in Warner Bros. Discovery Series A common stock occurred on December 10, 2025 (transaction date shown as 12/10/2025).
How many Warner Bros. Discovery Series A shares does the CFO own after these transactions?
After the reported transactions, the CFO beneficially owns 918,940 Series A common shares directly, plus 14,140 shares held as custodian and 13,045 shares held indirectly through a spouse.
Which employee stock options were exercised in the Warner Bros. Discovery CFO filing?
The CFO exercised employee stock options with exercise prices of $29.08 and $25.7 per share, covering 92,592 and 150,402 Series A shares, respectively. After these exercises, the Form 4 shows 0 derivative securities remaining for each option grant.
Were the Warner Bros. Discovery CFO's share dispositions made under a Rule 10b5-1 plan?
Yes. The explanation states that the CFO entered into a trading arrangement pursuant to Rule 10b5-1 on March 4, 2025 and that the reported sales were made pursuant to that trading arrangement.